Tuberculosis as a cause of death in HIV + patients in Africa: autopsy Autopsies on 108 HIV+ patients in Botswana (selected) Cause of death: Tuberculosis37%

Slides:



Advertisements
Similar presentations
June 2004 HITCH Training Slide Set #3 Special Considerations in Antiretroviral Therapy.
Advertisements

Delphine Sculier, MD,MPH Stop TB Department World Health Organisation Geneva, Switzerland Update on the revision of ART guidelines for TB patients.
Tuberculosis incidence and risk factors among adult patients receiving HAART in Senegal: a 7-year cohort study Assane DIOUF et al. IRD/UMR 145 CRCF, CHNU.
Wessex BASHH regional audit 2008 Dr Emma Rutland.
Mortality and causes of death among women living with HIV in the UK in the era of highly-active antiretroviral therapy Sara Croxford, A Kitching, M Kall,
PROGRAMMATIC OPERATIONAL RESEARCH DEVELOPMENT OF MALAWI’ S POLICY ON COTRIMOXAZOLE PREVENTIVE THERAPY R. Zachariah / AD Harries Contacts:
Chronic diseases in HIV Francois Venter Wits Reproductive Health & HIV Institute
CRYPTOCOCCAL INFECTIONS IN PATIENTS WITH AIDS Stephen J. Gluckman, M.D. Botswana-UPENN Partnership.
In the name of God Fariba Rezaeetalab Assistant Professor.
Cost-effectiveness of different starting criteria of antiretroviral therapy in Mexico. Caro Y., Colchero A., Valencia A., Bautista-Arredondo S., Sierra.
Unit 10 Treating the Dually Infected Patient: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.
SEPSIS Early recognition and management. Aims of the talk Understand the definition of sepsis and severe sepsis Understand the clinical significance of.
Reference Cooper BA, and the IDEAL study group. A randomized controlled trial of early versus late initiation of dialysis. N Engl J Med [Accessed.
HIV Early Treatment Project Groups 1 and 2 n Among HIV-infected participants in sub-Saharan Africa, does initiation of antiretroviral treatment (ART) at.
Unit 5: IPT Isoniazid TB Preventive Therapy
Standard of Care for MDR-TB
Impact evaluation Evaluate new tools Translate new knowledge into policy and implementation Knowledge gap Program implementation.
Autopsies in HIV: still finding missed diagnoses after 20 years Background Mortality has significantly fallen with the advent of HAART and chemoprophylaxis.
Increasing HIV treatment for TB patients – thinking out of the box Anthony D Harries, The Union Paris, France.
Is monitoring for CD4 counts still needed for the management of patients with long- term HIV RNA suppression? Andrew Hill, Liverpool University, UK.
Isoniazid preventive therapy for people living with HIV: Public health challenges and implementation issues Peter Godfrey-Faussett UNAIDS (with thanks.
1 Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Pulmonary Complications in HIV
Clinical Care of HIV, AIDS and Opportunistic Infections
1 Starting ART in the Context of Opportunistic Infections HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Hepatitis C+ Recipients: Considerations for Exclusion Emily A. Blumberg, M.D.
Office of Overseas Programming & Training Support (OPATS) Treatment Adherence HIV Care, Support, and Treatment.
Ukrainian TB mortality assessment 2008: Low HIV awareness and access to ART for TB patients associated with high HIV related TB mortality Presenting author:
Sanghyuk Shin, PhD Department of Epidemiology UCLA Fielding School of Public Health Aug 27, 2015 Tuberculosis and HIV Co-infection: “A Deadly Syndemic”
TUBERCULOSIS: THE LINKS WITH POVERTY Anthony D Harries The Union, Paris, France.
Approach To Pneumonia. Pneumonia Importance Mechanism Classification & its benefit Diagnosis Treatment.
HIV/TB – Case Studies David Schlossberg, MD, FACP Medical Director, TB Control Program Philadelphia Department of Health.
Update on HIV Therapy Elly T Katabira, FRCP Department of Medicine Makerere University Medical School Scaling up Treatment Programs: Issues, Challenges.
The Effectiveness of generic Highly Active Antiretroviral Therapy for the treatment of HIV infected Ugandan children Presenter: Linda Barlow-Mosha MD,
Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents Human Herpesvirus-8 Slide Set Prepared by the.
1 HIV Clinical Staging HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Efficacy of routine viral load, CD4 cell count, and clinical monitoring of adults taking antiretroviral therapy in Rural Uganda Alex Coutinho MD MPH DTM&H.
Strategic Information and the Control of Tuberculosis Brian Williams and Chris Dye TB programme, Monitoring and Evaluation, WHO.
Understanding temporal trends in HIV prevalence, incidence and ARV Dr Valerie Delpech Head of HIV surveillance Public Health England.
Prophylaxis of Opportunistic Infections
Transplantation in HIV Michelle Roland, MD Assistant Professor of Medicine UCSF Positive Health Program at SFGH.
Questions, Answers, and Explanations Infectious Diseases Blueprint.
1 Adherence to ARV Therapy and Resistance HAIVN Havard Medical School AIDS Initiative in Vietnam.
Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Predictors of Failure in Timely TB Treatment Completion, United States Carla Winston,PhD TB PEN Focal Point Open Forum June 5,
Starting ART in the setting of Opportunistic Infections in children
A Call to Action Children – The missing face of AIDS.
Response to Antiretroviral Treatment In an Ethiopian Hospital Samuel Hailemariam, MD, MPH; J Allen McCutchan, MD, MSc Meaza Demissie, MD, PMH, PHD; Alemayehu.
Prepared by the AETC National Coordinating Resource Center based on recommendations from the CDC, National Institutes of Health, and HIV Medicine Association/Infectious.
Slideset on: Emery S, Neuhaus JA, Phillips AN, et al. Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving.
CHILDREN and HIV.
Sashindran V K, Sashwat S, Kumar Suman,
CRYPTOCOCCAL INFECTIONS IN PATIENTS WITH AIDS
Cross-sectional assessment of patient outcomes using a systematic file review process: Results from 12,987 patient files Ambereen Jaffer, Gesine Meyer-Rath,
Dr Dawood Quiz questions.
HIV-associated TB mortality and blocks in the cascade
Blood Culture (Bacterial, Mycobacterial & Fungal)
PCP: management of co-infection
Effect of POC CD4 testing at HIV diagnosis on attrition prior to ART initiation among youth in Khayelitsha, South Africa Pre-treatment losses to care remains.
VALUE Trial design: Hypertensive patients at high cardiovascular risk were randomized to valsartan (n = 7,649) vs. amlodipine (n = 7,596). Results (p =
PCP in adults: Presentation , Treatment and Prophylaxis
24 July 2018 Treatment outcomes with bedaquiline use when substituted for second-line injectables in multidrug resistant tuberculosis: a retrospective.
Indian Scenario HIV Situation TB Situation
PCP: management of co-infection
When to START During an OI
Management of Immune Reconstitution Inflammatory Syndrome (IRIS)
JAK2 INHIBITORS AND ALLOGRAFTING
Cotrimoxazole Prophylaxis in HIV positive individuals Group A
Anthony D Harries Ministry of Health, Malawi
The IAS TB/HIV Research Prizes are awarded to:
Presentation transcript:

Tuberculosis as a cause of death in HIV + patients in Africa: autopsy Autopsies on 108 HIV+ patients in Botswana (selected) Cause of death: Tuberculosis37% Pneumonia14% Pneumocystis11% Kaposi’s sarcoma 7% Cryptococcosis 6% Other 25% - Ansari (Int J Tuberc 2002)

Pre-mortem or initial diagnosis in patients with disseminated TB Diagnosis Fatal cases Non-fatal cases (n=15)(n=5) Pre-mort Dx Initial Dx Pulmonary TB24 Extrapulm TB42 AIDS3 Malaria 6 PCP or pn7 Other4 - Kimambo et al, Capetown Intl TB, Nov 07

Disseminated TB cases (n=19) Treatment and outcome Death: 17 (89%) of 19 Survival: 3d – 18 mos (median 30d, mean 87d) Positive TB lab before death: 4 (21%) of 19 TB Rx before death: 7 (37%) of 19 2 survivors had TB Rx within 2 weeks of blood culture 5 fatal cases lived 1d, 2 wks, 2 mos, 5 mos, 8 mos

CD4 and TB microbiology Progressive fall in CD4 needs to be monitored for starting ART TB is most common cause of death from HIV – prompt and accurate reports from lab essential to reducing mortality.

Bakari:CD4 count and TB tests CD4 count results: –Affirming a diagnosis of Immunosuppression –Initiation of ART –Assessment of response to ARV –Diagnosis of IRIS TB test results: –Initiation of ART if has CD4 of cells/µl –Choice of ART regimen –Diagnosis of IRIS –Anti TB resistance

Mtei: Research setting test needed to answer research question concerning disease presence & classify disease as per research protocol (also for management) time of test results should be as per protocol since research schedule has to be adhered to inaccurate results give wrong research outcome; cannot answer research question; cannot contribute to science late results give inappropriate research conclusion; delays answer of research question; delays writing of reports; cause financial constraints